randomized double-blind placebo-controlled clinical trial
Showing 1 - 25 of >10,000
Spinal Cord Injuries, Neuropathic Pain Trial in Minneapolis (brivaracetam, Placebo)
Not yet recruiting
- Spinal Cord Injuries
- Neuropathic Pain
- brivaracetam
- Placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Dec 5, 2022
Diabetic Foot Ulcers Trial in Taipei (ON101 Cream, Placebo)
Completed
- Diabetic Foot Ulcers
- ON101 Cream
- Placebo
-
Taipei, TaiwanKueiho Chen
Jan 4, 2023
Covid19 Trial in Miami (ADX-629, Placebo)
Completed
- Covid19
- ADX-629
- Placebo
-
Miami, FloridaMedical Research Center of Miami II, Inc.
Sep 26, 2022
Irritable Bowel Syndrome of Diarrhea Type (IBS-D) Trial (OPS-2071, )
Not yet recruiting
- Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
- OPS-2071
- placebo
- (no location specified)
Jun 20, 2023
Bipolar I Disorder, Depression, Anxiety, Stress Trial (Magnesium vitamin B6, Placebo)
Not yet recruiting
- Bipolar I Disorder
- +2 more
- Magnesium vitamin B6
- Placebo
- (no location specified)
Apr 28, 2023
Skin Aging Trial in Granada (HA matrix ingredient, Placebo)
Recruiting
- Skin Aging
- HA matrix ingredient
- Placebo
-
Granada, SpainHospital Virgen de las Nieves
Apr 12, 2023
Osteo Arthritis Knee Trial in Ramsar (Black seed oil capsule, Placebo Black seed oil capsule)
Completed
- Osteo Arthritis Knee
- Black seed oil capsule
- Placebo Black seed oil capsule
-
Ramsar, Mazandaran, Iran, Islamic Republic ofRamsar international campus
Sep 7, 2023
Non-Alcoholic Fatty Liver Disease Trial in Jaipur (MXP22 (Probiotic and antioxidant capsule), Placebo (Microcrystalline
Recruiting
- Non-Alcoholic Fatty Liver Disease
- MXP22 (Probiotic and antioxidant capsule)
- Placebo (Microcrystalline Cellulose)
-
Jaipur, Rajashthan, India
- +1 more
Apr 7, 2023
Systemic Scleroderma Trial in Chelyabinsk, Saint Petersburg (Divozilimab, Placebo)
Recruiting
- Systemic Scleroderma
- Divozilimab
- Placebo
-
Chelyabinsk, Russian Federation
- +2 more
Feb 3, 2023
Irritable Bowel Syndrome Trial in Krynki, Stawiszyn (Vivatlac Synbiotikum)
Recruiting
- Irritable Bowel Syndrome
- Vivatlac Synbiotikum
-
Krynki, Poland
- +1 more
Feb 15, 2023
Acute Exacerbation of COPD Trial in Beijing (Xuanfei Baidu granule, Xuanfei Baidu granule Placebo)
Recruiting
- Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- Xuanfei Baidu granule
- Xuanfei Baidu granule Placebo
-
Beijing, ChinaPeking University People's Hospital
Nov 10, 2023
Acute Ischemic Stroke Trial (Tirofiban, Tirofiban simulant)
Not yet recruiting
- Acute Ischemic Stroke
- Tirofiban
- Tirofiban simulant
- (no location specified)
Sep 19, 2023
Rosacea, Rosacea Papular Type, Rosacea, Papulopustular Trial in Spain (Probiotic mixture, Placebo)
Recruiting
- Rosacea
- +2 more
- Probiotic mixture
- Placebo
-
Vigo, Pontevedra, Spain
- +3 more
Apr 4, 2023
Hyperlipidemia Trial in Beijing (JS401, Placebo)
Recruiting
- Hyperlipidemia
- JS401
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 15, 2023
Obesity Associated Disorder Trial in Foshan (Treatment with Akkermansia muciniphila, Treatment with )
Recruiting
- Obesity Associated Disorder
- Treatment with Akkermansia muciniphila
- Treatment with placebo
-
Foshan, Guangdong, ChinaThe Seventh Affiliated Hospital of Southern Medical University
Feb 7, 2023
IBS - Irritable Bowel Syndrome Trial (Normodigest Classic, Placebo)
Not yet recruiting
- IBS - Irritable Bowel Syndrome
- Normodigest Classic
- Placebo
- (no location specified)
Oct 3, 2022
Bacterial Vaginosis, Candidosis Vaginal, Urinary Tract Infections Trial in Catania (Lacticaseibacillus rhamnosus CA15 (DSM
Recruiting
- Bacterial Vaginosis
- +2 more
- Lacticaseibacillus rhamnosus CA15 (DSM 33960) probiotic strain
- placebo
-
Catania, ItalyUniversity of Catania
Apr 6, 2023
Chronic Kidney Failure in Children and Young Adults Trial (Dapagliflozin, Placebo)
Not yet recruiting
- Chronic Kidney Failure in Children and Young Adults
- Dapagliflozin
- Placebo
- (no location specified)
Jul 10, 2023
Group 3 Pulmonary Hypertension Trial (recombinant human brain natriuretic peptide, Placebo)
Not yet recruiting
- Group 3 Pulmonary Hypertension
- recombinant human brain natriuretic peptide
- Placebo
- (no location specified)
Jan 30, 2023
Moderate to Severe Plaque Psoriasis Trial in Saint Petersburg (BCD-085 Q2W, BCD-085 Q4W, Placebo)
Completed
- Moderate to Severe Plaque Psoriasis
- BCD-085 Q2W
- +2 more
-
Saint Petersburg, Strelna, Russian FederationBIOCAD
May 11, 2022
Weight Loss Trial in Pavia (Polyglucosamine L112, Placebo)
Enrolling by invitation
- Weight Loss
- Polyglucosamine L112
- Placebo
-
Pavia, Lombardia, ItalyAzienda di Servizi alla Persona Istituzioni Assistenziali Riunit
Mar 12, 2022
COPD Trial in Guangzhou (Ensifentrine, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Ensifentrine
- Placebo
-
Guangzhou, Guangdong, China1st Affiliated Hospital of Guangzhou Medical University
Feb 28, 2023
COVID-19 Trial in Sugar Land (HB-adMSCs, Placebos)
Completed
- COVID-19
- HB-adMSCs
- Placebos
-
Sugar Land, TexasHope Biosciences Stem Cell Research Foundation
Oct 26, 2022
Digestive Health, Gastrointestinal Health Trial in Guelph (Inulinase, Maltodextrin )
Not yet recruiting
- Digestive Health
- Gastrointestinal Health
- Inulinase
- Maltodextrin placebo
-
Guelph, Ontario, CanadaNutrasource site (Apex Trials)
Feb 24, 2023